Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...

Q4 2024 Earnings Call Transcript March 24, 2025 Operator: Hello, and welcome to the Moleculin Biotech Fourth Quarter and Full ...

SeaStar Medical Fourth Quarter and Year-End 2024 Financial Results Conference Call A replay of the call will be available after 7:30 pm ET and can be accessed as follows: The webcast replay is ...

By using AI, Iktos aims to speed up the drug discovery process while increasing the probability of success of drug candidates reaching clinical development ... to significantly accelerate drug ...

Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement ...

leverages AI and ML to speed up drug discovery and enable drug development to benefit cancer patients. The company claims that its AI platform, PEDAL, can predict the efficacy of medicines on ...